PRECISIONBIOLOGICS
Menu
↗
Vendor evaluation

Wharton's jelly supplier checklist for clinics and medspas

A documentation-first checklist for comparing Wharton's jelly suppliers on donor records, processing timelines, lot testing, and cold chain handling.

Reviewed 2026-10-27

Start with the donor and recovery record

Wharton's jelly is the gelatinous connective tissue of the umbilical cord, recovered at the time of a scheduled, full-term cesarean delivery from a consenting donor. Before comparing anything else, confirm that a supplier's donor program includes a documented medical and social history review and serology testing for communicable disease, and that donation is structured so it does not interfere with a mother's separate option to bank cord blood.

Ask whether tissue recovery is performed by trained, licensed personnel and how quickly recovered tissue moves into processing. A short, documented interval between recovery and processing is a basic marker of a controlled program.

Processing timelines and the standards a supplier describes following

Ask what window the supplier uses between tissue recovery and processing, and get it in writing rather than accepting a verbal estimate. PB tissue is processed within 48 hours of recovery; ask other suppliers to document their own processing window.

Ask which standards the supplier describes its processing as following, such as FDA regulations and AATB or AABB guidelines, and ask for the specific language used to describe that relationship. Being described as following industry guidelines is different from an independently verified certification; ask the supplier to clarify which applies.

Lot-level testing and release documentation

Every tissue lot should carry a unique lot identifier, and samples from each lot should be sent to a third-party laboratory for sterility testing. Ask the supplier to confirm, in writing, that each lot is held in quarantine until testing is complete and the supplier's internal release criteria are met before the lot ships to any clinic.

  • Unique lot identifier on every unit
  • Third-party sterility testing per lot
  • Written confirmation of quarantine-until-release
  • Certificate of analysis available for the specific lot you are purchasing

Cold chain and format considerations

Wharton's jelly products are supplied in more than one format, and handling requirements differ by format. If a format is cryopreserved, ask whether it is frozen using a slow-rate process, stored at -80 degrees Celsius, and shipped overnight on dry ice in validated containers. If a format is lyophilized (freeze-dried), ask whether it is described as shelf-stable without cryogenic storage, with handling and reconstitution instructions provided in the product insert that accompanies the lot.

Ask how the supplier documents temperature during shipping and what its defined process is if a shipment arrives outside the expected range.

Regulatory framework questions to ask any Wharton's jelly supplier

Human cell and tissue products are generally offered under the regulatory framework in 21 CFR 1271.10. Whether a specific intended use at your clinic meets all applicable criteria in that regulation is a determination for your practice and your own regulatory counsel, not a question a supplier can answer on your behalf. This section is general information, not legal advice, and any written regulatory position a supplier provides is worth having counsel review.

Account setup and ongoing verification

Orders should be restricted to licensed professionals, with account verification tied to an NPI number before a first order is processed. Ask whether the supplier offers access to physician-level conversations about product documentation, distinct from clinical advice, and whether lot traceability is maintained at the patient-record level once product reaches your clinic.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.

FAQ

Frequently asked questions

What is the single most important document to request from a Wharton's jelly supplier?+

The certificate of analysis for the specific lot you intend to purchase, tied to a unique lot identifier. General marketing materials are not a substitute for lot-specific documentation.

Is a cryopreserved or lyophilized Wharton's jelly format "better"?+

They differ in handling, not in a comparative performance claim this guide can make. Cryopreserved formats require -80 degree Celsius storage and dry ice shipping; lyophilized formats are described by suppliers as shelf-stable. Choose based on your clinic's storage capacity and workflow.

Does "described as following AATB and AABB guidelines" mean the facility is certified?+

Not automatically. Ask the supplier for the precise language it uses and whether supporting registration or licensure documentation is available for you to review directly, rather than assuming certification from a general statement.

Who decides whether our intended use qualifies under section 361?+

Your clinic, with your own regulatory counsel. A supplier can describe the framework its products are offered under, but the determination for a specific intended use belongs to you and your counsel. This is not legal advice.

Sources

  1. 21 CFR 1271.10 - Are my HCT/Ps regulated solely under section 361 of the PHS Act ↗eCFR
  2. Umbilical cord-derived Wharton's jelly for regenerative medicine: a systematic review ↗PMC8618385
  3. Critical evaluation of compositions and clinical relevance of Wharton's jelly-derived biologics ↗PMC12903654
  4. Colony forming potential and protein composition of commercial umbilical cord allograft products ↗Am J Sports Med